Form 424B2 JPMORGAN CHASE & CO
The information in this preliminary pricing supplement is not complete and may be changed. This preliminary pricing supplement is not an offer to sell nor does it seek an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.Subject to completion dated September 17, 2026
September , 2026
... (continue reading...)
Form DEFA14A REGIS CORP
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934 (Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
... (continue reading...)
Form 8-K AES CORP For: Sep 17
false000087476100008747612026-09-172026-09-17
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 17, 2026
... (continue reading...)
Form 144 Heartflow, Inc. Filed by: Verghese Vikram
html,body,div,span,applet,object,iframe,h1,h2,h3,h4,h5,h6,p,blockquote,pre,a,abbr,acronym,address,big,cite,code,del,dfn,em,font,img,ins,kbd,q,s,samp,small,strike,strong,sub,sup,tt,var,dl,dt,dd,ol,ul,li,fieldset,form,label,legend,table,caption,tbody,tfoot,thead,tr,th,td
{
margin: 0;
padding: 0;
border: 0;
outline: 0;
font-weight: inherit;
font-style: inherit;
font-size: 100%;
font-family: inherit;
vertical-align:... (continue reading...)
Form 8-K Ellington Financial Inc. For: Sep 17
FALSE000141134200014113422026-09-172026-09-170001411342us-gaap:CommonStockMember2026-09-172026-09-170001411342us-gaap:SeriesBPreferredStockMember2026-09-172026-09-170001411342us-gaap:SeriesCPreferredStockMember2026-09-172026-09-170001411342us-gaap:SeriesDPreferredStockMember2026-09-172026-09-17UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549FORM 8-KCURRENT REPORTPURSUANT TO SECTION 13 OR 15(d) OF THESECURITIES EXCHANGE ACT OF 1934Date of Report... (continue reading...)
More SEC Filings
View Older Stories-
Form D Your Dad LLC
-
Form 4 DXC Technology Co For: Sep 15 Filed by: Taylor Paul James
-
Form 10-K UPEXI, INC. For: Jun 30
-
Form 144 WEALTHFRONT CORP Filed by: Imberman Alan
-
Form 8-K Hub Group, Inc. For: Sep 16
-
Form 4 TWILIO INC For: Sep 15 Filed by: Dubinsky Donna
-
Form 144 NEXTNAV INC. Filed by: Shams Sammaad
-
Form 4 FORD MOTOR CO For: Sep 15 Filed by: FORD WILLIAM CLAY JR
-
Form 4 Medpace Holdings, Inc. For: Sep 15 Filed by: BURWIG SUSAN E
-
Form 144 MAGNITE, INC. Filed by: Knopper Douglas S
-
Form 8-K RED ROBIN GOURMET BURGER For: Sep 15
-
Form 144 Travere Therapeutics, Filed by: Dube Eric M
-
Form D TrueNoord Jet LP
-
Form 144 Harmony Biosciences Hold Filed by: Budur Kumar
-
Form 144 Twist Bioscience Corp Filed by: Leproust Emily M.
-
Form 424B2 BANK OF MONTREAL /CAN/
-
Form 4 MYRIAD GENETICS INC For: Sep 16 Filed by: Sikri Vishal
-
Form 144 Caris Life Sciences, Filed by: Brille Brian J
-
Form 3 Service Properties Trust For: Sep 15 Filed by: Cooney Jeanmarie
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 144 CG Oncology, Inc. Filed by: Bellete Ambaw
-
Form 4 NIKE, Inc. For: Sep 15 Filed by: Arnault Alexandre
-
Form 4 ALEXANDRIA REAL ESTATE For: Sep 15 Filed by: Kuhn Hallie E.
-
Form 144 Planet Labs PBC Filed by: Schingler Robert H
-
Form 4 ALEXANDRIA REAL ESTATE For: Sep 15 Filed by: Gossett Bret E.
-
Form 144 Enliven Therapeutics, Filed by: Hohl Benjamin
-
Form 4 ALEXANDRIA REAL ESTATE For: Sep 15 Filed by: Thomas Gregory Calvin
-
Form DEF 14A REGIS CORP For: Oct 28
-
Form 144 Klaviyo, Inc. Filed by: Whalen Amanda
-
Form 4 ALEXANDRIA REAL ESTATE For: Sep 15 Filed by: Stevens Blake L.
-
Form 8-K FIVE STAR BANCORP For: Sep 14
-
Form 144 CRESCENT BIOPHARMA, INC. Filed by: Brumm Joshua T
-
Form 4 ALEXANDRIA REAL ESTATE For: Sep 15 Filed by: Foger Jenna R.
-
Form 4 ALEXANDRIA REAL ESTATE For: Sep 15 Filed by: Boss Michael E.
-
Form 424B2 GOLDMAN SACHS GROUP INC
-
Form 424B2 BofA Finance LLC
-
Form 144 TANDEM DIABETES CARE Filed by: Novara Mark David
-
Form 144 CRESCENT BIOPHARMA, INC. Filed by: McNeill Jonathan
-
Form 4 ALEXANDRIA REAL ESTATE For: Sep 15 Filed by: Nelson Jesse J.
-
Form 144 SOUNDHOUND AI, INC. Filed by: SROKA DIANA
-
Form 4 ALEXANDRIA REAL ESTATE For: Sep 15 Filed by: Cole John Hart
-
Form 144 Venture Global, Inc. Filed by: Thayer Jonathan W
-
Form S-8 Arq, Inc.
-
Form SCHEDULE 13D/A Tyra Biosciences, Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
-
Form 144 WEALTHFRONT CORP Filed by: Lin Lauren
-
Form S-1/A NON INVASIVE MONITORING
-
Form 144 Cloudflare, Inc. Filed by: SEIFERT THOMAS J
-
Form 3 NIKE, Inc. For: Sep 15 Filed by: Arnault Alexandre
-
Form 4 HUBBELL INC For: Sep 15 Filed by: Mikes Mark Eugene

